Thermo Fisher Scientific Inc., a maker of medical and laboratory equipment with Lehigh Valley operations, will report first-quarter 2024 results Wednesday morning.
Wall Street analysts expect revenue for the quarter of $10.1 billion, based on a survey of eight analysts that was compiled by Zacks Investment Research. Earnings per share are projected to be $4.70, based on the consensus estimate of 10 analysts.
Shares of Waltham, Massachusetts-based Thermo Fisher have been trading well under their 52-week high of $603.82. On Monday, the closing price was $548.38. At Monday's price, the company has a market capitalization (number of shares outstanding times price) of $209 billion.
The company's 52-week low is $415.60. Shares fell in October after the company cut its full-year 2023 forecast.
Thermo Fisher will hold a conference call for investors at 8:30 a.m. Wednesday, after results are reported.
Thermo Fisher reports four business segments: life sciences, analytical instruments, specialty diagnostics, and its largest segment, laboratory products and biopharma services.
